IRIS
LOZZI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.502
EU - Europa 7.187
AS - Asia 3.878
SA - Sud America 664
AF - Africa 199
Continente sconosciuto - Info sul continente non disponibili 148
OC - Oceania 18
Totale 28.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.383
CN - Cina 1.633
GB - Regno Unito 1.559
RU - Federazione Russa 1.323
SG - Singapore 1.057
IE - Irlanda 921
IT - Italia 770
UA - Ucraina 632
SE - Svezia 604
BR - Brasile 535
DE - Germania 498
FR - Francia 406
VN - Vietnam 328
HK - Hong Kong 282
KR - Corea 204
FI - Finlandia 203
ZA - Sudafrica 109
IN - India 98
ES - Italia 70
CA - Canada 54
AR - Argentina 49
BD - Bangladesh 45
BE - Belgio 35
NG - Nigeria 33
PL - Polonia 33
NL - Olanda 30
JP - Giappone 29
MX - Messico 27
TR - Turchia 27
IQ - Iraq 20
PK - Pakistan 20
RO - Romania 20
CZ - Repubblica Ceca 18
EC - Ecuador 18
AT - Austria 16
AU - Australia 16
IR - Iran 15
CI - Costa d'Avorio 14
JO - Giordania 14
VE - Venezuela 14
CO - Colombia 12
PH - Filippine 12
ID - Indonesia 11
PY - Paraguay 11
AZ - Azerbaigian 9
CL - Cile 9
EU - Europa 9
IL - Israele 9
KE - Kenya 9
NP - Nepal 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
MA - Marocco 8
TN - Tunisia 8
JM - Giamaica 7
DZ - Algeria 6
KZ - Kazakistan 6
LB - Libano 6
LT - Lituania 6
PE - Perù 6
RS - Serbia 6
SA - Arabia Saudita 6
GR - Grecia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
UZ - Uzbekistan 5
BY - Bielorussia 4
CR - Costa Rica 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GD - Grenada 3
GE - Georgia 3
KG - Kirghizistan 3
MY - Malesia 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
GP - Guadalupe 1
Totale 28.447
Salva come PNG Salva come JPEG
Città #
Dallas 8.006
Southend 1.381
Dublin 914
Fairfield 812
Ashburn 686
Menlo Park 620
Singapore 593
Chandler 586
Jacksonville 495
Woodbridge 439
Santa Clara 379
Moscow 357
Beijing 348
Wilmington 348
Seattle 347
Houston 339
Ann Arbor 291
Cambridge 285
Hong Kong 277
San Jose 268
Hefei 246
Milan 218
Seoul 203
Siena 197
Nanjing 180
Princeton 169
Council Bluffs 165
The Dalles 110
Los Angeles 109
Johannesburg 105
Ho Chi Minh City 103
New York 98
Rome 96
Helsinki 87
Shanghai 84
Fremont 83
Lauterbourg 80
Boardman 77
Munich 73
Hanoi 72
San Mateo 69
Nanchang 67
Buffalo 61
São Paulo 51
Málaga 50
San Diego 50
Dong Ket 45
Dearborn 43
Shenyang 39
Orem 37
Abuja 33
Brussels 32
Changsha 31
Tianjin 30
Hebei 29
Redwood City 29
Turku 28
Figino 26
London 26
Warsaw 26
Chicago 25
Jiaxing 24
Toronto 24
Columbus 23
Bengaluru 22
Chennai 22
Kunming 22
San Francisco 22
Zhengzhou 21
Frankfurt am Main 20
Jinan 20
Tokyo 20
Washington 19
Amsterdam 18
Brooklyn 18
Florence 17
Boston 16
Belo Horizonte 15
Guangzhou 15
Rio de Janeiro 15
Turin 15
University Park 15
Abidjan 14
Brasília 14
Amman 13
Lancaster 13
Redondo Beach 13
Atlanta 12
Brno 12
Kansas City 12
Ningbo 12
Timisoara 12
Denver 11
Phoenix 11
Stockholm 11
Dhaka 10
Hangzhou 10
Hải Dương 10
Izmir 10
Manchester 10
Totale 21.766
Salva come PNG Salva come JPEG
Nome #
1 H‐ and natural abundance 15 N‐nmr studies of a derivative of a rabies glycoprotein fragment 7.484
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 388
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 370
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 359
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 348
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 337
A model of the rabies virus glycoprotein active site 324
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 321
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 317
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 311
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 299
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 295
Tumor imaging with tetrabranched neurotensin 273
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 273
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 271
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 263
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 262
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate camcer metastates, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2 262
Branched Neurotensin For Tumor Targeting 259
Bioactive peptides from libraries 255
Toxin-related antibodies with antimicrobial and antiviral activity 254
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 252
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 249
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 249
Branched peptides as targeting agents for tumor imaging and therapy 245
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 243
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 240
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 239
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 239
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 237
Highly fluorescent protein labeling using dendritic peptide derivatives 236
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 230
Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus 228
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 227
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 226
Synthetic peptides in the form of dendrimers become resistant to protease activity 224
Dynein heavy chain related polypeptides in growing pollen tube of Nicotiana tabacum 223
CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity 220
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid-chromatography 219
The antimicrobial peptide M33. An example of drug development 217
Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins 216
Branched neurotensin for tumor targeting 216
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 215
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 215
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 214
Interaction of Angiotensin II with the C-terminal 300-320 fragment of the rat Angiotensin II Receptor AT1a monitored by NMR 212
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 210
Tumor selective targeting by branched peptides 210
Binding of HIV-1 gp120 to the nicotinic receptor 209
Molecular basis of branched peptides resistance to enzyme proteolysis 207
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides 205
Synthetic peptides of rubella E1 glycoprotein for serological assays 204
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 204
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 203
High molecular weight polypeptides related to dynein heavy chains in Nicotiana tabacum pollen tubes 203
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 202
Micro-determination of amino acid composition of proteins electroblotted onto polyvinylidene difluoride membranes 201
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 195
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies 191
Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies 188
SNARE motif and neurotoxins 186
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 186
Synthetic antidotes against snake neurotoxins 185
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 184
Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides 183
Selection of catalytically active biotin ligase and trypsin mutants by phage display 179
Recognition of CMV pp65 protein antigen by human CD4 T cell lines induced with an immunodominant peptide pool 178
Epitopes identification by limited proteolysis 177
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 177
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies 176
Toxin-related antibodies with antimicrobial and antiviral activity 176
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 175
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85 172
The antimicrobial peptide M33. An example of drug development 171
Tumor imaging with tetrabranched neurotensin 171
The 208-222 Region of the peplomer Glycoprotein as a putative binding site of rabies virus with the nicotinic acetylcholine receptor 169
Branched neurotensin peptides for tumor targeting 168
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 167
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 167
Dendrimeric peptides for tumor targeting 161
Synthesis and purification of site-specific peptide conjugated to bovine pancreatic trypsin inhibitor 161
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66 161
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor 158
Polipeptidi correlati alle catene pesanti delle dineine in tubetti pollinici di Nicotiana tabacum 156
A strategy for isolation af catalytic activities from repertoires of enzymes displayed on phage 155
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell binding site 155
Natural analogue peptides of an HIV-1 GP-120 T-helper epitope antagonize response of GP-120 specific human CD4 T-cell clones 154
Histidyl tags and structural stabilization of linear peptides 154
New Developments in Heterocyclic Silyl Enol Ether Chemistry: Synthesis and Lewis Acid Mediated Reactions with Carbon Electrophiles of 2,5-bis(trimethylsiloxy)thiophene and 1-Methyl-2,5-bis(trimethylsiloxy)pyrrole 150
Synthetic inhibitors of anthrax lethal toxin 146
Resolution of Conformational Equilibria In Linear Peptides By Circular-dichroism In Cryogenic Solvents 144
Synthetic peptides in the form of dendrimers can become resistant to protease activity 143
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 141
On the structural stability of a small bioactive peptide of potential use in biotechnology 140
Recognition of human T-leukaemia virus (HTLV-1) envelope by human CD4+ - cell lines from HTLV-1 seronegative individuals: Specificity and clonal heterogeneity 136
Structurally driven selection of human hepatitis C virus mimotopes. 136
NMR studies of the interaction of alpha-bungarotoxin with a mimotope of the nicotinic acetylcholine receptor 134
Strong synthetic inhibitors of anthrax lethal toxin 128
Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willabrand factor 123
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 118
Totale 28.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.164 0 178 88 139 61 30 51 61 44 127 117 268
2022/20232.024 124 210 248 296 206 398 27 171 184 71 72 17
2023/20241.351 37 51 143 70 50 393 474 16 3 15 10 89
2024/20252.555 65 142 272 137 294 132 70 132 203 86 285 737
2025/202613.237 491 2.672 5.947 831 1.184 243 582 204 230 288 100 465
2026/2027351 214 137 0 0 0 0 0 0 0 0 0 0
Totale 28.596